Reply to “CSF Amyloid‐β Risk Stratification in CAA: A Missing Link for Anti‐Amyloid Therapy Safety”

Philipp Arndt, Stefanie Schreiber
Annals of Neurology · Wiley · 2026-10-22 · DOI: 10.1002/ana.78339

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles